Safety and efficacy of denosumab in osteoporotic hemodialysed patients.

CONCLUSIONS: Our pilot experience highlights the safety and efficacy of denosumab in the treatment of osteoporosis in HD patients, potentially supporting its use to reduce the burden of fractures in this patient population. PMID: 27394428 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27394428?dopt=Abstract

Source: Journal of Nephrology - July 8, 2016 Category: Urology & Nephrology Authors: Festuccia F, Jafari MT, Moioli A, Fofi C, Barberi S, Amendola S, Sciacchitano S, Punzo G, Menè P Tags: J Nephrol Source Type: research